Nissle 1917 Inhibits Biofilm Formation and Mitigates Virulence in

Overview

Journal Front Microbiol

Specialty Microbiology

Date 2023 Mar 27

PMID 36970701

Authors

Ahmad M Aljohani

Cecile El-Chami

Muna Alhubail

Ruth G Ledder

Catherine A ONeill

Andrew J McBain

Affiliations

Soon will be listed here.

Abstract

In the quest for mitigators of bacterial virulence, cell-free supernatants (CFS) from 25 human commensal and associated bacteria were tested for activity against . Among these, Nissle 1917 CFS significantly inhibited biofilm formation and dispersed extant pseudomonas biofilms without inhibiting planktonic bacterial growth. eDNA was reduced in biofilms following exposure to Nissle CFS, as visualized by confocal microscopy. Nissle CFS also showed a significant protective effect in a -based larval virulence assay when administrated 24 h before challenge with the No inhibitory effects against were observed for other tested strains. According to proteomic analysis, Nissle CFS downregulated the expression of several proteins involved in motility (Flagellar secretion chaperone FliSB, B-type flagellin fliC, Type IV pilus assembly ATPase PilB), and quorum sensing (acyl-homoserine lactone synthase lasI and HTH-type quorum-sensing regulator rhlR), which are associated with biofilm formation. Physicochemical characterization of the putative antibiofilm compound(s) indicates the involvement of heat-labile proteinaceous factors of greater than 30 kDa molecular size.

Citing Articles

Effects of Probiotics on Gut Microbiota: An Overview.

Chandrasekaran P, Weiskirchen S, Weiskirchen R Int J Mol Sci. 2024; 25(11).

PMID: 38892208 PMC: 11172883. DOI: 10.3390/ijms25116022.

A survey of multiple candidate probiotic bacteria reveals specificity in the ability to modify the effects of key wound pathogens.

Alhubail M, McBain A, ONeill C Microbiol Spectr. 2024; 12(6):e0034724.

PMID: 38700333 PMC: 11237428. DOI: 10.1128/spectrum.00347-24.

References

Hancock V, Dahl M, Klemm P . Probiotic Escherichia coli strain Nissle 1917 outcompetes intestinal pathogens during biofilm formation. J Med Microbiol. 2010; 59(Pt 4):392-399. DOI: 10.1099/jmm.0.008672-0. View

Durand E, Bernadac A, Ball G, Lazdunski A, Sturgis J, Filloux A . Type II protein secretion in Pseudomonas aeruginosa: the pseudopilus is a multifibrillar and adhesive structure. J Bacteriol. 2003; 185(9):2749-58. PMC: 154417. DOI: 10.1128/JB.185.9.2749-2758.2003. View

Ahn K, Baik J, Park O, Yun C, Han S . Lactobacillus plantarum lipoteichoic acid inhibits biofilm formation of Streptococcus mutans. PLoS One. 2018; 13(2):e0192694. PMC: 5805336. DOI: 10.1371/journal.pone.0192694. View

de la Fuente-Nunez C, Korolik V, Bains M, Nguyen U, Breidenstein E, Horsman S . Inhibition of bacterial biofilm formation and swarming motility by a small synthetic cationic peptide. Antimicrob Agents Chemother. 2012; 56(5):2696-704. PMC: 3346644. DOI: 10.1128/AAC.00064-12. View

Zhang L, Hinz A, Nadeau J, Mah T . Pseudomonas aeruginosa tssC1 links type VI secretion and biofilm-specific antibiotic resistance. J Bacteriol. 2011; 193(19):5510-3. PMC: 3187457. DOI: 10.1128/JB.00268-11. View

Breidenstein E, Khaira B, Wiegand I, Overhage J, Hancock R . Complex ciprofloxacin resistome revealed by screening a Pseudomonas aeruginosa mutant library for altered susceptibility. Antimicrob Agents Chemother. 2008; 52(12):4486-91. PMC: 2592849. DOI: 10.1128/AAC.00222-08. View

Abdelhamid A, Esaam A, Hazaa M . Cell free preparations of probiotics exerted antibacterial and antibiofilm activities against multidrug resistant . Saudi Pharm J. 2018; 26(5):603-607. PMC: 6035330. DOI: 10.1016/j.jsps.2018.03.004. View

Theuretzbacher U, Piddock L . Non-traditional Antibacterial Therapeutic Options and Challenges. Cell Host Microbe. 2019; 26(1):61-72. DOI: 10.1016/j.chom.2019.06.004. View

Moman R, ONeill C, Ledder R, Cheesapcharoen T, McBain A . Mitigation of the Toxic Effects of Periodontal Pathogens by Candidate Probiotics in Oral Keratinocytes, and in an Invertebrate Model. Front Microbiol. 2020; 11:999. PMC: 7308727. DOI: 10.3389/fmicb.2020.00999. View

10.

Helmy Y, Kassem I, Kumar A, Rajashekara G . Evaluation of the Impact of the Probiotic Nissle 1917 on 's Invasion and Intracellular Survival in Human Colonic Cells. Front Microbiol. 2017; 8:1588. PMC: 5572226. DOI: 10.3389/fmicb.2017.01588. View

11.

Defoirdt T . Quorum-Sensing Systems as Targets for Antivirulence Therapy. Trends Microbiol. 2017; 26(4):313-328. DOI: 10.1016/j.tim.2017.10.005. View

12.

Petrova M, Imholz N, Verhoeven T, Balzarini J, Van Damme E, Schols D . Lectin-Like Molecules of Lactobacillus rhamnosus GG Inhibit Pathogenic Escherichia coli and Salmonella Biofilm Formation. PLoS One. 2016; 11(8):e0161337. PMC: 4990349. DOI: 10.1371/journal.pone.0161337. View

13.

Doghri I, Brian-Jaisson F, Graber M, Bazire A, Dufour A, Bellon-Fontaine M . Antibiofilm activity in the culture supernatant of a marine sp. bacterium. Microbiology (Reading). 2020; 166(3):239-252. DOI: 10.1099/mic.0.000878. View

14.

Jiang Y, Kong Q, Roland K, Wolf A, Curtiss 3rd R . Multiple effects of Escherichia coli Nissle 1917 on growth, biofilm formation, and inflammation cytokines profile of Clostridium perfringens type A strain CP4. Pathog Dis. 2014; 70(3):390-400. PMC: 4038294. DOI: 10.1111/2049-632X.12153. View

15.

Meuskens I, Saragliadis A, Leo J, Linke D . Type V Secretion Systems: An Overview of Passenger Domain Functions. Front Microbiol. 2019; 10:1163. PMC: 6555100. DOI: 10.3389/fmicb.2019.01163. View

16.

Bidossi A, De Grandi R, Toscano M, Bottagisio M, De Vecchi E, Gelardi M . Probiotics Streptococcus salivarius 24SMB and Streptococcus oralis 89a interfere with biofilm formation of pathogens of the upper respiratory tract. BMC Infect Dis. 2018; 18(1):653. PMC: 6292094. DOI: 10.1186/s12879-018-3576-9. View

17.

Wei X, Gao J, Wang F, Ying M, Angsantikul P, Kroll A . In Situ Capture of Bacterial Toxins for Antivirulence Vaccination. Adv Mater. 2017; 29(33). PMC: 5581250. DOI: 10.1002/adma.201701644. View

18.

Ross-Gillespie A, Weigert M, Brown S, Kummerli R . Gallium-mediated siderophore quenching as an evolutionarily robust antibacterial treatment. Evol Med Public Health. 2014; 2014(1):18-29. PMC: 3935367. DOI: 10.1093/emph/eou003. View

19.

Braun V . Energy-coupled transport and signal transduction through the gram-negative outer membrane via TonB-ExbB-ExbD-dependent receptor proteins. FEMS Microbiol Rev. 1995; 16(4):295-307. DOI: 10.1111/j.1574-6976.1995.tb00177.x. View

20.

Rodrigues S, Paillard C, Dufour A, Bazire A . Antibiofilm Activity of the Marine Bacterium Pseudoalteromonas sp. 3J6 Against Vibrio tapetis, the Causative Agent of Brown Ring Disease. Probiotics Antimicrob Proteins. 2014; 7(1):45-51. DOI: 10.1007/s12602-014-9173-3. View